Our study also showed that patients with PTMC are more likely to carry Rad50 gene mutations than are those without cancer, which may be related to the decrease in DNA binding and the tether and nuclease functions of the MRN complex caused by Rad50 mutation, resulting in a decrease in DSB repair capacity. Here, RAD50 is linked to cancer.